Schatz Michael, Zeiger Robert S, Vollmer William M, Mosen David, Cook E Francis
Department of Allergy, Kaiser-Permanente Medical Center, San Diego, CA 92111, USA.
J Allergy Clin Immunol. 2006 Nov;118(5):1048-53. doi: 10.1016/j.jaci.2006.07.057. Epub 2006 Oct 6.
Asthma control has been hypothesized to be inversely related to asthma severity, directly related to effective management, and also related to other definable factors, but empiric data to support this construct are few.
We sought to identify independent prospective determinants of future long-term asthma control among asthma severity, management, demographic, and comorbidity predictors.
Surveys were completed by a random sample of 2250 health maintenance organization members aged 18 to 56 years with persistent asthma. Linked computerized pharmacy data provided baseline and follow-up year medication dispensings. The outcome was follow-up year long-term asthma control, as assessed by using a previously validated 4-level scale based on the number of short-acting beta-agonist canister dispensings.
Oral corticosteroids (odds ratio [OR], 1.9) or unscheduled visits (OR, 1.2) in the prior year, any prior asthma hospitalizations (OR, 1.4), smoking (OR, 2.2), chronic obstructive pulmonary disease (OR, 1.9), male sex (OR, 1.5), black race (OR, 1.3), and lower educational level (OR, 1.1) were independently associated with poorer control in ordinal logistic regression analyses. Regular inhaled corticosteroids (OR, 0.7), long-acting beta-agonists (OR, 0.7) and asthma specialist care (OR, 0.6) were independently associated with better control.
Markers of asthma severity and other patient characteristics are inversely related to future asthma control, but effective management strategies are associated with improved asthma control, even after accounting for these high-risk characteristics.
Inhaled corticosteroids, long-acting beta-agonists, and asthma specialist care are associated with improved asthma control, even after accounting for markers of asthma severity.
有假设认为,哮喘控制与哮喘严重程度呈负相关,与有效管理呈正相关,还与其他可明确的因素有关,但支持这一概念的实证数据很少。
我们试图在哮喘严重程度、管理、人口统计学和共病预测因素中,确定未来长期哮喘控制的独立前瞻性决定因素。
对2250名年龄在18至56岁之间患有持续性哮喘的健康维护组织成员进行随机抽样调查。关联的计算机化药房数据提供了基线和随访年度的药物配给情况。结局指标是随访年度的长期哮喘控制情况,采用基于短效β受体激动剂吸入器配给数量的先前验证的4级量表进行评估。
在前一年使用口服糖皮质激素(比值比[OR],1.9)或非计划就诊(OR,1.2)、有任何既往哮喘住院史(OR,1.4)、吸烟(OR,2.2)、慢性阻塞性肺疾病(OR,1.9)、男性(OR,1.5)、黑人种族(OR,1.3)以及较低教育水平(OR,1.1)在有序逻辑回归分析中与较差的控制独立相关。规律使用吸入性糖皮质激素(OR,0.7)、长效β受体激动剂(OR,0.7)和哮喘专科护理(OR,0.6)与更好的控制独立相关。
哮喘严重程度指标和其他患者特征与未来哮喘控制呈负相关,但即使考虑了这些高危特征,有效的管理策略仍与改善哮喘控制相关。
即使考虑了哮喘严重程度指标,吸入性糖皮质激素、长效β受体激动剂和哮喘专科护理仍与改善哮喘控制相关。